Novavax Stock: A Great Opportunity To Buy On Post-Earnings Weakness
Luis Alvarez/DigitalVision via Getty Images
Investment Thesis
Novavax (NVAX) released earnings on the same day after Moderna (MRNA). While Moderna reported a blockbuster Q2 following its strong momentum from Q1, Novavax reported that the company is “continuing…
